Skip to content
drillr.ai
Sign up

LYCA

Lycia Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$27.73
+10.70%
Ask drillr
6
Insider buys (3m)
0
Insider sells (3m)
$37.7M
Net value (3m)
—
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 27, 2026Venrock Healthcare Capital Partners III, L.P. · 10 percent ownerPurchase24,560$26
Oct 27, 2026Venrock Healthcare Capital Partners III, L.P. · 10 percent ownerPurchase28,379$26
Oct 27, 2026Venrock Healthcare Capital Partners III, L.P. · 10 percent ownerPurchase1,944,444$18
Oct 27, 2026Venrock Healthcare Capital Partners III, L.P. · 10 percent ownerPurchase8,261$27
Oct 27, 2026Venrock Healthcare Capital Partners III, L.P. · 10 percent ownerPurchase8,729$26
Oct 27, 2026Venrock Healthcare Capital Partners III, L.P. · 10 percent ownerPurchase31,067$27
Oct 26, 2026Fischer Laurent · directorA-Award13,307$3.70
Oct 26, 2026Fischer Laurent · directorA-Award20,000$18
Oct 26, 2026Henderson Jane · directorA-Award57,666$3.70
Oct 26, 2026Henderson Jane · directorA-Award20,000$18
Oct 26, 2026RIEFLIN WILLIAM JL · directorA-Award24,840$3.70
Oct 26, 2026RIEFLIN WILLIAM JL · directorA-Award20,000$18
Oct 26, 2026Touami Sofia · officer: Chief Business OfficerA-Award68,755$3.70
Oct 26, 2026Staben Steven · 10 percent owner, officer: Chief Scientific OfficerA-Award110,896$3.70
Oct 26, 2026Lee Chin Hyok · 10 percent owner, officer: Chief Medical OfficerA-Award73,191$3.70
Oct 26, 2026Bachrodt Amy · 10 percent owner, officer: Chief Financial OfficerA-Award399,746$3.70
Oct 26, 2026Trombley Aetna Wun · director, 10 percent owner, officer: President and CEOA-Award443,586$3.70

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 27, 2026